On Jan 4th results from #Contraline's successful first-in-human early-stage trial dropped in and demonstrated reversibility. This is another really important milestone in reaching #reproductiveAutonomyForAll
https://www.wired.com/story/male-contraceptive-contraline-vasalgel-hydrogel/
#vasDeferens #vasalgel #maleContraception
#nextLifeSciences #ParsemusFoundation #MaleContraceptiveInitiative
#Vasalgel, die dauerhafte, aber reversible Verhütungsmethode für Männer: Das Produkt #PlanA kommt voran, hier kann man sich für nen NL eintragen:
https://www.planaformen.com/join
Mehr Infos: https://www.planaformen.com
a 2023 comprehensive overview on the development of hormonal and non-hormonal approaches to reversible #MaleContraception
> It is long overdue that male partners share the burden of #familyPlanning, and it is the authors’ hope that this will soon be a possibility.
https://bacandrology.biomedcentral.com/articles/10.1186/s12610-023-00204-z
#vasDeferens #vasalgel #nestorone #eppin #SLO3 #sACInhibition #ADAM #contralineInc #RISUG
Background Since the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning. Over 60 years later, this is still the case as the only practical, effective contraceptive options available to men are condoms and vasectomy. However, there are now a variety of promising hormonal and non-hormonal male contraceptive options being studied. The purpose of this narrative review is to provide clinicians and laypeople with focused, up-to-date descriptions of novel strategies and targets for male contraception. We include a cautiously optimistic discussion of benefits and potential drawbacks, highlighting several methods in preclinical and clinical stages of development. Results As of June 2023, two hormonal male contraceptive methods are undergoing phase II clinical trials for safety and efficacy. A large-scale, international phase IIb trial investigating efficacy of transdermal segesterone acetate (Nestorone) plus testosterone gel has enrolled over 460 couples with completion estimated for late 2024. A second hormonal method, dimethandrolone undecanoate, is in two clinical trials focusing on safety, pharmacodynamics, suppression of spermatogenesis and hormones; the first of these two is estimated for completion in December 2024. There are also several non-hormonal methods with strong potential in preclinical stages of development. Conclusions There exist several hurdles to novel male contraception. Therapeutic development takes decades of time, meticulous work, and financial investment, but with so many strong candidates it is our hope that there will soon be several safe, effective, and reversible contraceptive options available to male patients.
I missed this, but it appears that clinical trial on #Vasalgel may start this year
"$1.55M Raised for Plan A™ Male Birth Control Product, Seeking Clinical Trials in 2023"
@MicroCheapFx et la ptite video du contexte, plutôt bien faite : https://youtu.be/x4fjbx-WR4Q
#Risug #Vasalgel dans le game, 10ans (au moins) après les premières infos !!
Kann ich jetzt bitte endlich dieses verfluchte #Vasalgel bekommen? Es ist 2019, du patriarchale Scheißwelt!
(Artikel ⬇️ ist von 2015 und irgendwie fehlte wohl Geld, um die Zulassungen zu erwerben 🤬)
Jaxom Kaplan
Maxi 12x 💉
Xdej
Kanaillenvogel
Ash_Crow
Homer S.